Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression
- PMID: 21418204
- DOI: 10.1111/j.1365-2362.2011.02514.x
Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression
Abstract
Background: The multiligand receptor for advanced glycation end products (RAGE) of the immunoglobulin superfamily is expressed on multiple cell types implicated in the inflammatory response in atherosclerosis. We sought to determine the role of bone marrow-derived RAGE in different stages of atherosclerotic development in apolipoprotein E-deficient mice (apoE(-/-)).
Methods: Seven- and 23-week-old apoE(-/-) mice (n = 40) were lethally irradiated and given bone marrow from RAGE null (RAGE(-/-)/apoE(-/-)) or RAGE-bearing (RAGE(+/+)/apoE(-/-)) mice to apoE(-/-) mice to generate double knockout bone marrow chimera (RAGE(-/-)/apoE(-/-bmc) and RAGE(+/+)/apoE(-/-bmc)-, respectively). After 16 weeks on a standard chow diet, mice were sacrificed and atherosclerotic lesion formation was evaluated.
Results: Plaques in the aortic root of the young mice showed no significant difference in maximum plaque size (217,470 ± 17,480 μm(2) for the RAGE(-/-) /apoE(-/-bmc) mice compared to 244,764 ± 45,840 μm(2)), whereas lesions in the brachiocephalic arteries of the older RAGE(-/-)/apoE(-/-bmc) mice had significantly smaller lesions (94,049 ± 13,0844 μm(2) vs. 145,570 ± 11,488 μm(2), P < 0.05) as well as reduced average necrotic core area (48,600 ± 9220 μm(2) compared to 89,502 ± 10,032 μm(2), P < 0.05) when compared to RAGE(+/+)/apoE(-/-bmc) mice. Reduced plaque size and more stable plaque morphology was associated with significant reduced expression of VCAM-1, ICAM-1 and MCP-1. Accumulation of the RAGE ligand HMGB-1 was also significantly reduced within the lesions of RAGE(-/-)/apoE(-/-bmc) mice.
Conclusions: This study demonstrates that bone marrow-derived RAGE is an important factor in the progression of atherosclerotic plaques.
© 2011 The Authors. European Journal of Clinical Investigation © 2011 Stichting European Society for Clinical Investigation Journal Foundation.
Similar articles
-
Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis.Clin Sci (Lond). 2014 Oct;127(7):485-97. doi: 10.1042/CS20140045. Clin Sci (Lond). 2014. PMID: 24724734
-
Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.Cardiovasc Res. 2010 May 1;86(2):321-9. doi: 10.1093/cvr/cvq032. Epub 2010 Jan 28. Cardiovasc Res. 2010. PMID: 20110335
-
Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.Circ Cardiovasc Imaging. 2008 Nov;1(3):212-9. doi: 10.1161/CIRCIMAGING.108.788299. Circ Cardiovasc Imaging. 2008. PMID: 19808545
-
RAGE (receptor for advanced glycation end products): a central player in the inflammatory response.Microbes Infect. 2004 Nov;6(13):1219-25. doi: 10.1016/j.micinf.2004.08.004. Microbes Infect. 2004. PMID: 15488742 Review.
-
99mTc-Labeled anti-receptor for advanced glycation endproducts monoclonal antibody F(ab’)2 fragments.2010 Jul 16 [updated 2010 Aug 16]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Jul 16 [updated 2010 Aug 16]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20734503 Free Books & Documents. Review.
Cited by
-
Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke.Int J Mol Sci. 2013 Sep 13;14(9):18899-924. doi: 10.3390/ijms140918899. Int J Mol Sci. 2013. PMID: 24065095 Free PMC article. Review.
-
Insulin resistance, hyperglycemia, and atherosclerosis.Cell Metab. 2011 Nov 2;14(5):575-85. doi: 10.1016/j.cmet.2011.07.015. Cell Metab. 2011. PMID: 22055501 Free PMC article. Review.
-
22016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis and Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage.Arterioscler Thromb Vasc Biol. 2017 Apr;37(4):613-621. doi: 10.1161/ATVBAHA.117.307263. Epub 2017 Feb 9. Arterioscler Thromb Vasc Biol. 2017. PMID: 28183700 Free PMC article. Review.
-
Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes.Diabetologia. 2014 Sep;57(9):1977-85. doi: 10.1007/s00125-014-3291-z. Epub 2014 Jun 24. Diabetologia. 2014. PMID: 24957662
-
C-reactive protein stimulates RAGE expression in human coronary artery endothelial cells in vitro via ROS generation and ERK/NF-κB activation.Acta Pharmacol Sin. 2015 Apr;36(4):440-7. doi: 10.1038/aps.2014.163. Epub 2015 Mar 23. Acta Pharmacol Sin. 2015. PMID: 25832424 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous